Opportunity
SAM #36C26226Q0977
Solicitation for FDA-Approved Blood Bank Reagents for VISN 22 Medical Centers
Buyer
VA 262 Network Contract Office 22
Posted
July 01, 2026
Respond By
July 22, 2026
Identifier
36C26226Q0977
NAICS
424210, 325413
The Department of Veterans Affairs, Network Contracting Office 22, is soliciting an IDIQ contract for FDA-approved blood bank reagents and consumables for VISN 22 Medical Centers. - Government Buyer: - Department of Veterans Affairs, Network Contracting Office 22 (VISN 22 Sites) - Products/Services Requested: - FDA-approved blood bank reagents and consumables (no equipment or services) - Key reagents include: - Cells for ABO back-typing - Complement check cells - IgG check cells - LISS (Low Ionic Strength Solution) - Monoclonal Control / RH Control - Anti-A1 Lectin - 22% Bovine Serum Albumin - Elution Kit - Anti IgG - Anti C3b, C3d - Anti-IgG C3d - Competency testing kit - PEG (Polyethylene glycol) - Various anti-sera (including Anti-C, -c, -E, -e, -Lea, -Leb, -K, M, N, Fya, Fyb, S, s, Jka, Jkb) - Antibody identification panels (at least 30 unique donor cells) - Full antigen profile with extended antigen typing by DNA analysis (covering a wide range of antigens) - OEMs and Vendors: - No specific OEMs or vendors are named; products must be FDA-approved - Unique/Notable Requirements: - All reagents must be FDA-approved - Antibody identification panels must include at least 30 unique donor cells - Extended antigen typing by DNA analysis is required - Equipment and services are specifically excluded - Supplies will be ordered as needed under an IDIQ contract - Period of Performance: - Five years total: base year plus four one-year option periods
Description
See attached